35 articles, transcripts, and reports
Vertex Pharmaceuticals (Nasdaq: VRTX) today reported first quarter financial results for the period ended March 31, 2020. On GAAP basis, first quarter EPS was $2.29…
Biotechnology is the one industry that has been showing signs of improvement in the COVID-19 affected market. This week a bunch of biotech companies is…
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) continues to be in the luxury of escaping from the COVID-19 pandemic crisis. The stock reflected the comfort of the…
— Vertex Pharmaceuticals, Inc. (NASDAQ: VRTX) reported earnings of $1.70 per share in the fourth-quarter 2019, vs. $1.20 per share expected. — Total revenue rose 63% to…
— Vertex Pharmaceuticals (NASDAQ: VRTX) reported third-quarter 2019 earnings of $1.23 per share, vs. $1.15 per share expected — Total revenue grew 21% to $949.8…
